Phibro Animal Health (PAHC) Other Working Capital Changes (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Other Working Capital Changes of $603000.0 in Q1 2026, up 107.97% quarter-over-quarter from -$7.6 million in Q4 2025, and down 69.47% on a YoY basis from $2.0 million in Q1 2025.
Phibro Animal Health (PAHC) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Working Capital Changes history runs 14 years deep, the most recent figure standing at $603000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 69.47% year-over-year to $603000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 1714.68% YoY), while the FY2025 annual figure was $16.3 million, up 248.06% from the prior year.
- Other Working Capital Changes was $603000.0 for Q1 2026 at Phibro Animal Health, up from -$7.6 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $8.6 million in Q2 2025 to a low of -$7.6 million in Q2 2024.
- Historically, Other Working Capital Changes has averaged $430117.6 across 5 years, with a median of $306000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 54971.43% in 2022, then tumbled 12162.9% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $62000.0 in 2022, then plunged by 8537.1% to -$5.2 million in 2023, then surged by 190.96% to $4.8 million in 2024, then tumbled by 259.0% to -$7.6 million in 2025, then jumped by 107.97% to $603000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $603000.0 (Q1 2026), -$7.6 million (Q4 2025), and $306000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603,000.00 |
| Mar 31, 2026 | 603,000.00 |
| Dec 31, 2025 | -7.57 Mn |
| Dec 31, 2025 | -7.57 Mn |
| Sep 30, 2025 | 306,000.00 |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 8.63 Mn |
| Jun 30, 2025 | 8.63 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 979,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | -7.60 Mn |
| Jun 30, 2024 | -7.60 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Dec 31, 2023 | -5.23 Mn |
| Dec 31, 2023 | -5.23 Mn |